<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Health Technologies KTN News via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Health Technologies KTN News' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Health+Technologies+KTN+News&t=Health+Technologies+KTN+News&s=Search&f=source]]></link>
        <lastBuildDate>Sat, 03 Apr 2010 14:29:46 +0100</lastBuildDate>
        <item>
            <title>UK-PharmSci 2010 - The Science of Medicines - call for papers</title>
            <link>http://www.medworm.com/index.php?rid=3229175&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.ukpharmsci.org%2FDefault.asp</link>
            <description>The Academy of Pharmaceutical Scientists are pleased to announce the Inaugural Science Conference of the Academy of Pharmaceutical Sciences - UK-PharmSci 2010 ...The Science of Medicines. This will be the premier conference for pharmaceutical scientists in the United Kingdom in 2010.
 CALL FOR PAPERS
Abstracts Submissions for poster and podium presentations are now being accepted. Please visit http://www.ukpharmsci.org/Default.asp for further information and registration. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3229175</comments>
            <pubDate>Tue, 02 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3229175</guid>        </item>
        <item>
            <title>CALL FOR EPSRC/ HEALTHTECH AND MEDICINES KTN INDUSTRIAL CASE STUDENTSHIPS AWARDS for 2010</title>
            <link>http://www.medworm.com/index.php?rid=3214176&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fhtm-ktn-case2010</link>
            <description>The HealthTech and Medicines KTN will be able to support five industrial CASE Studentships for awards that are due to start in the academic year 2010/2011. These CASE Studentships provide an excellent mechanism for engaging universities and industry in our Network through training and technology transfer.We are looking for high quality Industrial Case Studentship proposals in line with the priority areas for health technologies and medicine sectors identified by the EPSRC and development of new generations of medical and implantable devices.The technical scope is broad with the main emphasis on encouraging adventurous research for improved health technologies, whilst engaging with the industrial and clinical base to provide a route to the market.Proposals should be received by the KTN elec...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3214176</comments>
            <pubDate>Thu, 28 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3214176</guid>        </item>
        <item>
            <title>Medipex Yorkshire and Humber NHS Innovation Awards and Showcase 2010</title>
            <link>http://www.medworm.com/index.php?rid=3180916&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.futurehealthtech.org%2Fdocs%2FMedipex%2520NHS%2520Innovation%2520Awards%2520and%2520Showcase%25202010.pdf</link>
            <description>The Innovation Awards &amp; Showcase 2010 aims to identify individuals and teams working for the NHS whose ideas or inventions have directly led to or could lead to improvements in patient care and must be capable of being scaled up for wider implementation across the NHS.
The competition is open to all NHS staff in the Yorkshire and Humber region (individuals and teams) OR anyone working with an NHS employee in this area (e.g. a company, a university employee or an individual).

Entries will not be accepted after 5pm on Friday 26th February 2010
Entries can only be submitted online, via email or through the post and must be typed

The AwardsFinalists will be invited to attend an awards ceremony and dinner on 21st April 2010 when the winners will be announced. The prize money will be given...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3180916</comments>
            <pubDate>Mon, 18 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3180916</guid>        </item>
        <item>
            <title>California - UK collaborative opportunity in translational stem cell research - disease team call for proposals</title>
            <link>http://www.medworm.com/index.php?rid=3180915&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.mrc.ac.uk%2FFundingopportunities%2FCalls%2FMRC_CIRM%2FMRC005564</link>
            <description>The Medical Research Council (MRC) has agreed to partner the Californian Institute of Regenerative Medicine (CIRM) in its Disease Team Request for Applications (RFA), which aims to progress preclinincal stem cell research towards clinical testing. The MRC is therefore calling for proposals from UK groups active in the preclinical domain that can link to Californian research teams to establish high quality, multidisciplinary translational research programmes. Funded programmes will be milestone-driven and have the maturity and critical mass to reach the stage of a phase I clinical trial within four years.
See http://www.mrc.ac.uk/Fundingopportunities/Calls/MRC_CIRM/MRC005564 for further information.
Inform MRC of intention to apply by 4:00 pm (GMT),9 March 2009Preliminary applications deadl...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3180915</comments>
            <pubDate>Mon, 18 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3180915</guid>        </item>
        <item>
            <title>Furlong Research Charitable Foundation Studentship Proposals Call</title>
            <link>http://www.medworm.com/index.php?rid=3180914&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.frcf.org.uk</link>
            <description>The Furlong Research Charitable Foundation is announcing its first call for proposals in 2010. 
 The 1st call will be aimed at PhD and MD studentship research projects ONLY. Each call invites proposals addressing important issues related to orthopaedics and musculoskeletal research. 
 The closing date for the Expression of Interests (EoI) is 1st April 2010. 
 For more information please visit: http://www.frcf.org.uk (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3180914</comments>
            <pubDate>Mon, 18 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3180914</guid>        </item>
        <item>
            <title>NIHR Invention for Innovation (i4i) Programme: 5th Call for proposals: Stream 1 - i4i Feasibility studies</title>
            <link>http://www.medworm.com/index.php?rid=3173745&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nihr-ccf.org.uk%2Fsite%2Fprogrammes%2Fi4i</link>
            <description>The National Institute for Health Research (NIHR) would like to invite project proposals of up to 12 months under its i4i Programme to determine first if prior basic research or an innovative use of an existing technology can be used to meet an existing or emerging healthcare need. There should be the potential for a device, based on the technology or technologies, to be developed through further applied R&amp;D. The study must also identify the barriers that would need to be overcome before implementation. Funding to a total of Â£100K is available.All applications must show innovation and must have relevance, impact and potential to contribute to future health gain for patients and the general population. This programme is open to all research providers in the UK academic and NHS communitie...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3173745</comments>
            <pubDate>Fri, 15 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3173745</guid>        </item>
        <item>
            <title>Fighting Infection Through Detection Competition -  Optional Briefing Event 27th January 2010</title>
            <link>http://www.medworm.com/index.php?rid=3154750&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.innovateuk.org%2Fevent%2Fevent%2Foptional-briefing-fighting-infection-through-detec.ashx</link>
            <description>The Technology Strategy Board is launching a competition with up to £11m available to fund feasibility studies, fast-track projects and larger R&amp;D projects. The Technology Strategy Board will invest up to £10m, and the Department of Health (DoH) will invest up to £1m. The aim of the competition is to support the development and uptake of diagnostic devices that will reduce the social and economic impact of infectious agents in animals and humans, and create opportunity and wealth for UK industry. Registration for the competition briefing event is now OPEN. The event will be held at the Hilton Paddington, with registration from 10am. Please visit the TSB web site for further information and registration. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3154750</comments>
            <pubDate>Fri, 08 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3154750</guid>        </item>
        <item>
            <title>70 million pound boost for UK manufacturing - Government funding for regenerative medicines</title>
            <link>http://www.medworm.com/index.php?rid=3150798&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fybkh7r7</link>
            <description>The HealthTech and Medicines KTN welcomes today's announcement by Lord Mandelson that the Engineering and Physical Sciences Research Council (EPSRC) will invest £5.3 million over the next five years in a Centre for Innovative Manufacturing in Regenerative Medicine at Loughborough University. The centre will also receive £3 million from 28 industrial and government partners. 
Regenerative Medicine has been heralded by the KTN as a strategic area for the UK which, with appropriate investment, can secure our position as a global leader in a newly emerging industry within healthcare.  The KTN will be an active participant in the Centre and will use our strong networking links with business and government to help drive outputs which are commercially relevant and adoptable. 
In addition this i...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3150798</comments>
            <pubDate>Thu, 07 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3150798</guid>        </item>
        <item>
            <title>NIHR i4i Programme 3rd Call for Applications i4i Funding Streams 3a (FPD3a) and 3b (FPD3b)</title>
            <link>http://www.medworm.com/index.php?rid=3041622&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nihr-ccf.org.uk%2Fsite%2Fprogrammes%2Fi4i%2F</link>
            <description>The NIHR Invention for Innovation (i4i) programme would like to invite submissions of applications to funding streams 3a and 3b (FPD3a and FPD3b).Stream 3a applications must include collaboration between at least one industry and one research (academic or clinical) partner aiming to determine the commercial viability of a proposed device or technology, with the development of a robust route to market and a strong, appropriate consortia serving as key deliverables. Primarily expected to be the first stage of a full collaborative applied research project, total project costs can be no more than £100K in total, of which 75% funding is available. Stream 3b applications should build on the results of a completed assessment of feasibility and must also have collaboration between at least one in...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3041622</comments>
            <pubDate>Mon, 30 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3041622</guid>        </item>
        <item>
            <title>FP7-HEALTH-2010-Alternative-Testing: What is in for you?</title>
            <link>http://www.medworm.com/index.php?rid=3028093&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fbit.ly%2F6hr5rs</link>
            <description>The FP7 Call for Proposals on Alternative Testing Strategies -FP7-HEALTH-2010-Alternative-Testing- foresees a budget of EUR 25 million of EU funding for 7 topics (6 Integrating Projects and 1 Coordinating Action) while COLIPA (The Cosmetics Industry Association) has announced its commitment to equal to the contribution of the EC, providing additional funding of up to EUR 25 million. The call deadline is 3 February 2010.
â¢	Eligible costs will be funded up to 100%: 50% EU funding and 50% COLIPA funding for all cost categories! 
â¢	For each of the topics, the minimum and maximum amounts mentioned on the call fiche only relate to the EC contribution.  
â¢	FP 7 rules apply for proposal submission, evaluation, GA negotiation and reporting .  
â¢	FP7 Grant Agreement and COLIPA st...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3028093</comments>
            <pubDate>Thu, 26 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3028093</guid>        </item>
        <item>
            <title>Vacancy -  Chair of NICE  Diagnostics Advisory Committee</title>
            <link>http://www.medworm.com/index.php?rid=3020609&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nice.org.uk%2Fgetinvolved%2Fjoinnwc%2FChairDiagnosticsAdvisoryCommittee.jsp</link>
            <description>The National Institute for Health and Clinical Excellence (NICE) is looking to recruit a candidate to chair its independent Diagnostics Advisory Committee.
This Committee will consider and interpret evidence on the clinical and cost effectiveness of diagnostic technologies as defined in the relevant EU directives, and formulate recommendations to the Institute on their use in the National Health Service. Diagnostic technologies within the Committeeâs remit will include pathological tests, imaging, endoscopy and physiological measurement. NICE will be considering diagnostic technologies used for various purposes including diagnosis, clinical monitoring, screening (not population screening programmes), treatment triage, assessing stages of disease progression, and risk stratification. T...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3020609</comments>
            <pubDate>Mon, 23 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3020609</guid>        </item>
        <item>
            <title>National Institute for Health and Clinical Excellence (NICE) seeks members of the Diagnostics Advisory Committee</title>
            <link>http://www.medworm.com/index.php?rid=3020608&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nice.org.uk%2Fgetinvolved%2Fjoinnwc%2FMemberDiagnosticsAdvisoryCommittee.jsp</link>
            <description>This Committee will consider and interpret evidence on the clinical and cost effectiveness of diagnostic technologies as defined in the relevant EU directives, and formulate recommendations to the Institute on their use in the National Health Service. Diagnostic technologies within the Committeeâs remit will include pathological tests, imaging, endoscopy and physiological measurement. NICE will be considering diagnostic technologies used for various purposes including diagnosis, clinical monitoring, screening (not population screening programmes), treatment triage, assessing stages of disease progression, and risk stratification.Committee members come from a wide range of backgrounds and disciplines, and include NHS professionals, academics, lay people and industry. They do not repres...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3020608</comments>
            <pubDate>Mon, 23 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3020608</guid>        </item>
        <item>
            <title>Japanese Ministry of Economy, Trade and Industry (METI) to set up committee for supporting medical devices industry</title>
            <link>http://www.medworm.com/index.php?rid=3001645&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fy8pcu9n</link>
            <description>In November 2009 METI will set up a committee to support SMEs in the medical devices industry in taking their technologies to market. The committees first step will be to establish a network for information exchange. Policies to support SMEs are currently under-developed, but the government has recognised the need to demonstrate and support Japans strengths in manufacturing in order to enhance its global competitiveness. (26 October 2009, Nikkan Kogyo Shimbun) (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3001645</comments>
            <pubDate>Wed, 18 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3001645</guid>        </item>
        <item>
            <title>New NICE programme to evaluate medical technologies established</title>
            <link>http://www.medworm.com/index.php?rid=2997439&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nice.org.uk</link>
            <description>The National Institute for Health and Clinical Excellence is launching a new programme focusing specifically on the evaluation of innovative medical technologies (including devices and diagnostics). This new programme will both complement and operate in conjunction with NICE's existing technology appraisal capacity, which will continue to evaluate new pharmaceutical and biotechnology products.
The Evaluation Pathway Programme for Medical Technologies will help enable new medical technologies, or important modifications of existing ones, to be used more quickly and consistently in the NHS. The types of products which might be included are medical devices that deliver treatment such as those implanted during surgical procedures, technologies that give greater independence to patients, and di...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2997439</comments>
            <pubDate>Mon, 16 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2997439</guid>        </item>
        <item>
            <title>UK University seeks partners for FP7 bid in nanoscaffolds</title>
            <link>http://www.medworm.com/index.php?rid=2956548&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fyh7k5p9</link>
            <description>A UK University is looking for partners to join a consortium they are looking to establish to bid for FP7 funding under the topic - NMP.2010.2.3-1 - Development of standard scaffolds for the rational design of bioactive materials for tissue regeneration - LARGE. The project aims to develop 3D bioactive nanocomposite scaffolds with pre-designed surface topography and biological patterns for bone and osteochondral tissue regeneration. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2956548</comments>
            <pubDate>Wed, 04 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2956548</guid>        </item>
        <item>
            <title>Senexis novel approach wins erbi award for innovation</title>
            <link>http://www.medworm.com/index.php?rid=2949273&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fy99yya5</link>
            <description>Sponsor HealthTech &amp; Medicines KTN celebrates culture of mutual support.Novel science caught the eye of judges for the 2009 ERBI Award for Innovation. Senexis work targeting Alzheimer's disease was seen to offer new approaches, within an exciting area of emerging science, directed at a growing area of unmet need.Senexis CEO Mark Treherne accepted the award from sponsor Sue Dunkerton, Director of HealthTech &amp; Medicines KTN. Sue Dunkerton comments that through the awards ERBI is helping to celebrate success and support the culture of innovation and continuous improvement:
&quot;To truly exploit their ideas companies need the ability to steer their way through the innovation and adoption processes. One key word is perseverance, which companies need in spades, and the East of England has an amazing...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2949273</comments>
            <pubDate>Mon, 02 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2949273</guid>        </item>
        <item>
            <title>GE Launches $250 Million Healthymagination Fund</title>
            <link>http://www.medworm.com/index.php?rid=2918040&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.healthymaginationfund.com</link>
            <description>New equity investment fund to invest in high potential healthcare technology companies; Supports GEs global Healthymagination initiative, focusing on cost, access and quality.

Fairfield, CT, USA  October 21, 2009  GE (NYSE: GE) announced today the formation of the GE Healthymagination Fund, a new equity fund that will make investments in highly promising healthcare technology companies. The fund will invest in companies globally that have innovative diagnostic, IT, and life sciences technologies aligned with the strategic objectives of GEs Healthymagination initiative. The fund will also support healthcare companies developing innovative and unique business models and services. 

The formation of the fund is part of GEs $6 billion Healthymagination initiative, a global commi...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2918040</comments>
            <pubDate>Thu, 22 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2918040</guid>        </item>
        <item>
            <title>New SBRI competitions created</title>
            <link>http://www.medworm.com/index.php?rid=2918041&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.innovateuk.org%2Fdeliveringinnovation%2Fsmallbusinessresearchinitiative%2Fcompetitions.ashx</link>
            <description>The NHS National Innovation Centre was established by the Department of Health to identify challenges within the NHS and act as a gateway for industry to bring solutions to those challenges. Through their 'Wouldn't It Be Great If' clinical needs identification process they have highlighted a number of areas needing innovative approaches to improve outcomes for patients.

From the output of this clinical needs process, four new SBRI competitions have been created. 

1. Paediatric Non-invasive Technologies
Looking for innovative and emerging technologies to enable non-invasive (or minimally invasive) tests to be performed at the bedside, in the community or in the home. 
2. Paediatric Improved Diagnostics for Children
Looking for new tests to rapidly diagnose conditions in children, includin...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2918041</comments>
            <pubDate>Wed, 21 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2918041</guid>        </item>
        <item>
            <title>2009 ERBI Awards deadline extended</title>
            <link>http://www.medworm.com/index.php?rid=2840398&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.erbi.co.uk</link>
            <description>It has been a challenging year for all in the lifescience arena and this has highlighted a need for new scientific and business strategies to exploit emerging technologies. The winners of the 2009 ERBI awards will be announced at Bench2Boardroom, a conference at which representatives from all sectors of the industry will debate the models required to create high growth businesses.Bench2Boardroom is to be held on October 21st at Chilford Hall, Linton, near Cambridge in the heart of Europe's largest lifescience cluster. It offers the opportunity for specialist suppliers to showcase their services alongside a lively conference which explores developments in three exciting areas - Consumer Electronics in Healthcare; Regenerative Medicine and Drug Re-purposing.The ERBI awards recognise and rewa...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2840398</comments>
            <pubDate>Mon, 28 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2840398</guid>        </item>
        <item>
            <title>NIHR Invention for Innovation (i4i) Programme 4th Call for proposals -  i4i Future Product Development - Funding Stream 1 (FPD1)</title>
            <link>http://www.medworm.com/index.php?rid=2822191&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nihr-ccf.org.uk%2Fsite%2Fprogrammes%2Fi4i</link>
            <description>The National Institute for Health Research (NIHR) would like to invite FPD1 project proposals of up to £100K for a maximum duration of 12 months under its i4i Programme to investigate whether a piece of prior basic research or an innovative use of an existing technology can be used to meet an existing or emerging healthcare need. There should be the potential for a device, based on the technology or technologies, to be developed through further applied R&amp;D. The study must also identify the barriers that would need to be overcome before implementation.All applications must show innovation and must have relevance, impact and potential to contribute to future health gain for patients and the general population. This programme is open to all research providers in the UK academic and NHS commu...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2822191</comments>
            <pubDate>Wed, 23 Sep 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2822191</guid>        </item>
        <item>
            <title>Battlefield Medical Technology: Call for proposals</title>
            <link>http://www.medworm.com/index.php?rid=2791715&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.science.mod.uk%2Fevents%2Fevent_detail.aspx%3Feventid%3D35</link>
            <description>The MoD is seeking innovative research in the area of Battlefield Medical Technology, where Technology is defined in the broadest possible sense as &quot;the application of practical sciences to industry or commerce, the methods, theory and practices of such application and the total knowledge and skills available.&quot; It is likely to focus on the current military medical priorities of Quality of Survival, Battlefield Analgesia and Medical Force Protection. Any developments in this area should consider their effects on Theatre Medical Sustainment which seeks to provide and sustain medical support to deployed forces in theatre through the optimisation of casualty evacuation and treatment timelines, and the provision of appropriate treatment facilities, medical equipment and supplies. This call is b...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2791715</comments>
            <pubDate>Mon, 14 Sep 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2791715</guid>        </item>
        <item>
            <title>Development of model agreements for collaborative commercial research</title>
            <link>http://www.medworm.com/index.php?rid=2764146&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.ukcrc.org%2Fregulationgovernance%2Fmodelagreements%2Fcommercialcollaborativeagree.aspx</link>
            <description>In June 2009 the UKCRC held a workshop to assess the need for and explore the possibility of developing model agreements for collaborative commercial research. The workshop was attended by key stakeholders including those from the pharmaceutical and devices industries, the health service, universities and innovation specialists. A report of this meeting is now available to download. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2764146</comments>
            <pubDate>Fri, 04 Sep 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2764146</guid>        </item>
        <item>
            <title>Feasibility Studies for Technology-Inspired Innovation: SEPTEMBER 2009  COMPETITION FOR FUNDING</title>
            <link>http://www.medworm.com/index.php?rid=2742753&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fkkw6m7</link>
            <description>The Technology Strategy Board proposes to stimulate innovation across its core technology areas to help ensure that UK businesses are well-equipped to respond to the challenges presented by the current downturn. We have allocated up to £1m to invest in feasibility studies lasting up to three months and each costing no more than £33,000 in total. We will fund 75% of the project cost (up to around £25,000). This competition will focus on feasibility studies:


	in technology areas closely aligned with the prioritised pillars of our various technology strategies 
	that contain an element of technology innovation that are both led and undertaken by small and micro companies individually or in partnership, 
	where the single company or collaborative partners spend most of the funding in-hous...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2742753</comments>
            <pubDate>Fri, 28 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2742753</guid>        </item>
        <item>
            <title>UK leads European research programme with 10 million pound investment in bioscience data handling capacity</title>
            <link>http://www.medworm.com/index.php?rid=2739356&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.ebi.ac.uk%2FInformation%2FNews%2Fpdf%2FELIXIR%252025_8.pdf</link>
            <description>The UK has made its first substantial commitment to a major emerging pan-European science project with a £10M investment (25 August) by the Biotechnology and Biological Sciences Research Council (BBSRC).BBSRC has awarded funding to the European Molecular Biology Laboratorys European Bioinformatics Institute (EMBL-EBI), based at Hinxton near Cambridge, to permit a dramatic increase in the institutes data storage and handling capacity. The funding is the first step in developing the existing data resources and IT infrastructure of EMBL-EBI towards its planned role as the central hub of the emerging European Life-Science Infrastructure for Biological Information (ELIXIR), placing the UK at the forefront of this multinational initiative. The estimated total cost of establishing ELIXIR is ...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2739356</comments>
            <pubDate>Fri, 28 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2739356</guid>        </item>
        <item>
            <title>1.5 million pound investment aims to give the UK Regenerative Medicine sector a business boost</title>
            <link>http://www.medworm.com/index.php?rid=2732020&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fkqfhef</link>
            <description>UK regenerative medicine companies are being offered the opportunity to compete for an investment package designed to enable them to boost their productivity. 
The government-backed Technology Strategy Board has launched a 1.5m collaborative R and D competition call, setting businesses the challenge of developing a better understanding of the best ways to make a profit from regenerative medicine. 

Zahid Latif, Lead Technologist in Biosciences, Medicines and Healthcare for the Technology Strategy Board said: 

Regenerative medicine companies operate in an emerging business sector, in an international environment where delivery of regenerative medicine could take on a number of different guises as the products and services are developed. The number of UK companies working in this field ha...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2732020</comments>
            <pubDate>Wed, 26 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2732020</guid>        </item>
        <item>
            <title>Competitions to Provide Solutions to Priority Clinical Needs</title>
            <link>http://www.medworm.com/index.php?rid=2728310&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nic.nhs.uk</link>
            <description>A new website is available through the NHS National Innovation Centre (NIC) that identifies priority clinical needs and links innovators to funding to support the development of solutions.

An initial set of six priority clinical needs, which were defined during the recent NHS Innovations EXPO workshops, are now available for review under the Competition Section of www.nic.nhs.uk.
These Competitions are now open and ideas for funding can be submitted through the online portal. The key features of these competitions include: 
 Competition for ideas and new technologies 
 Fully funded development contracts  not a grant 
 Fast-track, simplified process 
 Suitable for SMEs 
 Public sector organisation acts as lead customer 
 Should result in a commercial product/service 

For fur...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2728310</comments>
            <pubDate>Mon, 24 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2728310</guid>        </item>
        <item>
            <title>American Joint Replacement Registry announced</title>
            <link>http://www.medworm.com/index.php?rid=2802268&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.devicelink.com%2Fmtprecision%2Fblog%2F%3Fp%3D403</link>
            <description>The American Academy of Orthopaedic Surgeons (AAOS) has incorporated the American Joint Replacement Registry, a nonprofit organisation for collecting and reporting on hip and knee joint replacement procedures. AAOS believes this is a patient safety best practice: the goal of any national joint registry is to monitor device performance, so as to allow early recognition of underperforming processes or devices, and support continued clinical learning.
Medical DeviceLink, Jul 2009: http://www.devicelink.com/mtprecision/blog/?p=403 (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2802268</comments>
            <pubDate>Wed, 19 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2802268</guid>        </item>
        <item>
            <title>Electrospun fibres can eliminate toxins, mimic natural tissues</title>
            <link>http://www.medworm.com/index.php?rid=2710579&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.devicelink.com%2Fmpmn%2Farchive%2F09%2F07%2F006.html</link>
            <description>Researchers at Massachusetts Institute of Technology are exploring new ways to create, enhance, and employ electrospun fibres for medical device applications. Using a variety of polymers, they have used electrospinning processes to form fibres continuously and achieved diameters ranging from 0.1 to 1 µm. The team are experimenting with enhancing the fibres for drug-delivery and tissue-engineering applications, such as modifying the fibres by incorporating a bactericide or chemically reactive compound into a solution with the polymer so that it is reactive to a certain chemical toxin when the fibre is spun.
Medical DeviceLink, Jul 2009: http://www.devicelink.com/mpmn/archive/09/07/006.html (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2710579</comments>
            <pubDate>Wed, 19 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2710579</guid>        </item>
        <item>
            <title>Minimally invasive robots target tumours</title>
            <link>http://www.medworm.com/index.php?rid=2710578&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fmedtechinsider.com%2F%3Fp%3D8095</link>
            <description>The Israeli Institute of Technology has developed a robot - the ViRob - that can crawl through human veins to perform precise medical procedures, and could potentially diagnose and treat artery blockage and cancer. Researchers have produced a basic prototype of the device, and possible applications include delivering drugs to targeted areas to treat lung cancer, and harvesting samples from various parts of the body. The ViRob has tiny arms that allow it to stabilise against blood pressure. It is powered by an external magnetic field, can be controlled for long periods of time during procedures and achieves speeds of 9 mm/second.
medtechinsider, 23 Jul 2009: http://medtechinsider.com/?p=8095 (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2710578</comments>
            <pubDate>Wed, 19 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2710578</guid>        </item>
        <item>
            <title>American Joint Replacement Registry announced</title>
            <link>http://www.medworm.com/index.php?rid=2710577&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.devicelink.com%2Fmpmn%2Fblog%2F%3Fp%3D1754</link>
            <description>The American Academy of Orthopaedic Surgeons (AAOS) has incorporated the American Joint Replacement Registry, a nonprofit organisation for collecting and reporting on hip and knee joint replacement procedures. AAOS believes this is a patient safety best practice: the goal of any national joint registry is to monitor device performance, so as to allow early recognition of underperforming processes or devices, and support continued clinical learning.
Medical DeviceLink, Jul 2009: http://www.devicelink.com/mpmn/blog/?p=1754 (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2710577</comments>
            <pubDate>Wed, 19 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2710577</guid>        </item>
        <item>
            <title>Transducer technology may help shrink ultrasonic cutting devices</title>
            <link>http://www.medworm.com/index.php?rid=2710576&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.devicelink.com%2Fmpmn%2Fblog%2F%3Fp%3D1705</link>
            <description>Researchers from three UK universities are developing transducer technology that does not operate in resonance, allowing the design of smaller ultrasonic cutting instruments. Their aim is to create devices that surgeons could use to perform minimally invasive procedures on delicate areas of the body such as the spine. Current systems have to be resonant, so the device must be tuned to the operating frequency and this dictates what size the device has to be. The researchers are developing ultrasonic cutting instruments that will incorporate flextensional transducers providing an amplified longitudinal motion.
Medical DeviceLink, Jul 2009: http://www.devicelink.com/mpmn/blog/?p=1705 (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2710576</comments>
            <pubDate>Wed, 19 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2710576</guid>        </item>
        <item>
            <title>Royal Society Innovation Grants</title>
            <link>http://www.medworm.com/index.php?rid=2693456&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Froyalsociety.org%2Fpage.asp%3Fid%3D1112</link>
            <description>Industry Fellowship Scheme 

This scheme aims to enhance knowledge transfer in science and technology between those in industry and those in academia. It provides opportunities for an academic scientist to work on a collaborative project with industry, or someone employed in industry to work on a collaborative project with a university department or a not-for-profit research organisation. It is anticipated that fellows will establish personal and corporate links between the two sectors in the UK as a foundation for their long-term future development. These appointments are funded by the Royal Society, the Engineering and Physical Sciences Research Council, the Biotechnology and Biological Sciences Research Council, the Natural Environment Research Council, Rolls-Royce plc and Astra Zeneca....</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2693456</comments>
            <pubDate>Wed, 12 Aug 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2693456</guid>        </item>
        <item>
            <title>NICE to provide more advice on effective new devices and diagnostics</title>
            <link>http://www.medworm.com/index.php?rid=2655312&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nice.org.uk%2Fnewsroom%2Ffeatures%2FAdviceOnDevicesDiagnostics.jsp</link>
            <description>NICE has been asked by the Department of Health to coordinate the evaluation of innovative medical devices and diagnostics used in the NHS. The new work programme follows recognition in Lord Darzis Next Stage Review of the need to improve the process of identifying, evaluating and adopting effective new medical devices and diagnostics. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2655312</comments>
            <pubDate>Fri, 31 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2655312</guid>        </item>
        <item>
            <title>NIHR Invention for Innovation (i4i) Programme - 2nd Call</title>
            <link>http://www.medworm.com/index.php?rid=2655311&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nihr-ccf.org.uk%2Fsite%2Fprogrammes%2Fi4i%2F</link>
            <description>2nd Call for proposals - i4i Future Product Development - Funding Streams 3a (FPD3a) and 3b (FPD3b)
The NIHR's Invention for Innovation (i4i) programme would like to invite submissions of proposals to its Future Product Development 3a and 3b funding streams (FPD3a and FPD3b). FPD3a proposals must include collaboration between at least one industry and one research (academic or clinical) partner to determine the commercial viability of a proposed device or technology, with the development of a robust route to market and a strong, appropriate consortia being the main deliverables. Serving primarily as the first stage of a full collaborative applied research project, total project costs can be no more than £100K in total, of which 75% funding is available. 
FPD3b proposals of up to 3 years,...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2655311</comments>
            <pubDate>Fri, 31 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2655311</guid>        </item>
        <item>
            <title>Medical Research Council announces funding for seven awards totalling 4.7 million pounds under its translational stem cell research scheme</title>
            <link>http://www.medworm.com/index.php?rid=2623526&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.mrc.ac.uk%2FNewspublications%2FNews%2FMRC006229</link>
            <description>The Medical Research Council has announced funding for seven awards totalling £4.7 million under its translational stem cell research scheme. This includes nearly £3 million for four early stage clinical trials involving adult stem cells.These trials will assess various aspects of stem cell biology  using stem cell transplantation to address blindness and bone repair, to activate dormant stem cells within the body to treat Addisons disease and to target the elimination of cancerous stem cells responsible for chronic myeloid leukaemia. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2623526</comments>
            <pubDate>Wed, 22 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2623526</guid>        </item>
        <item>
            <title>INNOVATE 09 - 13 October 2009, London</title>
            <link>http://www.medworm.com/index.php?rid=2618176&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.innovate09.co.uk%2Fpreregistration.aspx</link>
            <description>Innovate 09  the Technology Strategy Boards annual exhibition and conference - gives you the opportunity to explore the tools, practices and solutions that will enable you to innovate and see the benefits now, and in the future. The day-long event will address all aspects of technology innovation, with special focus on the Technology Strategy Boards priorities - energy and low carbon technologies, healthcare and digital. Hear from business, government and academic leaders as they share with you the critical solutions and opportunities that innovating in these focus areas will deliver. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2618176</comments>
            <pubDate>Tue, 21 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2618176</guid>        </item>
        <item>
            <title>Publication of the latest National Institute for Health Research Progress Report</title>
            <link>http://www.medworm.com/index.php?rid=2618177&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nihr.ac.uk%2Ffiles%2Fpdfs%2FNIHR%2520Health%2520Report%2520final.pdf</link>
            <description>The NIHR Progress Report for 2008/09 was launched at the NIHR West Midlands 10 July 2009 Regional Conference: Committed to better research in the NHS, by Professor Dame Sally C. Davies.
The report gives an account of the NIHRs achievements in developing the infrastructure, programmes and the systems to facilitate health research in England and re-states the government's commitment to making the NHS in England a centre of excellence for health research. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2618177</comments>
            <pubDate>Mon, 20 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2618177</guid>        </item>
        <item>
            <title>Office for Life Sciences Blueprint published</title>
            <link>http://www.medworm.com/index.php?rid=2618180&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.dius.gov.uk%2Fols</link>
            <description>The Office for Life Sciences has developed a package of actions to transform the UK environment for life sciences companies. These actions have been agreed across Government, and with industry, the Higher Education sector and the NHS. A full list is set out in the Life Sciences Action Plan, published on 14 July 2009, which is downloadable from http://www.dius.gov.uk/ols (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2618180</comments>
            <pubDate>Wed, 15 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2618180</guid>        </item>
        <item>
            <title>Government aims for 1 billion pound venture capital fund to invest in the businesses of the future</title>
            <link>http://www.medworm.com/index.php?rid=2618178&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fnldurn</link>
            <description>The Prime Minister has announced the creation of the UK Innovation Investment Fund to invest in technology-based businesses with high growth potential. The new fund will focus on investing in growing small businesses, start-ups and spin-outs, in digital and life sciences, clean technology and advanced manufacturing. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2618178</comments>
            <pubDate>Wed, 15 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2618178</guid>        </item>
        <item>
            <title>PHOTONICS4LIFE Networking for better health care</title>
            <link>http://www.medworm.com/index.php?rid=2582168&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.photonics4life.eu</link>
            <description>PHOTONICS4LIFE (www.photonics4life.eu) is a European Network of Excellence in Biophotonics, formed in May 2008, which is funded by the European Commission within the 7th Framework Programme (FP7). It aims to provide a coherent framework for the strongly fragmented field of Biophotonics in Europe and to stimulate dialogue between industry and research institutions as well as between scientists and clinicians, which is known to be important for promoting innovation in the healthcare sector.
Today Biophotonics is an emerging multidisciplinary research area, embracing all light-based technologies applied to the life sciences and medicine. Enhancing diagnosis, therapy and follow-up care, Biophotonics drives the trend towards personalised medicine and plays a crucial role in limiting health-care...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2582168</comments>
            <pubDate>Fri, 03 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2582168</guid>        </item>
        <item>
            <title>CRO version of the model Clinical Investigation Agreement for medical   technology research conducted in NHS hospitals published</title>
            <link>http://www.medworm.com/index.php?rid=2558025&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nihr.ac.uk%2FPages%2Fdefault.aspx</link>
            <description>The Contract Research Organisations (CRO) version of the model Clinical Investigation Agreement for medical technology research conducted in NHS hospitals was published on 26/6/09. It can be found through the following links:
http://www.nihr.ac.uk/Pages/default.aspx
 http://www.abhi.org.uk/technical_regulatory/groups/clin_invest.aspx
 http://www.ukcrc.org/regulationgovernance/modelagreements/cromcia.aspx
The Agreement is intended to be used in unmodified format to enable the faster set up of commercial Clinical Investigations which are outsourced to CROs, as one of a number of bureaucracy-busting measures to improve the NHS clinical research environment for industry. Versions for use in the Devolved Administrations have been produced. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2558025</comments>
            <pubDate>Wed, 01 Jul 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2558025</guid>        </item>
        <item>
            <title>New SBRI Competitions in Prosthetics and Automatic Imagery Extraction</title>
            <link>http://www.medworm.com/index.php?rid=2491193&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.innovateuk.org%2Fsbri</link>
            <description>The MoD has announced two new SBRI competitions that are due to open in July 2009.  The first of these is looking for innovative research on Prosthetics, and opens on the 16th July with a seminar at Harwell.  The MoD has a high obligation for duty of care to help retain personnel in-service and minimise disability on discharge. This call focuses on two specific areas of treatment research related to amputation and similar complex traumas. The first is the physiological and repair process and the second is functional restoration and retraining.  These subjects cover a wide range of topics and will be of interest to a large spectrum of SMEs, academia and industries.  Interested companies should register at http://www.science.mod.uk
The second competition is in the field of Automatic Imagery ...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2491193</comments>
            <pubDate>Wed, 17 Jun 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2491193</guid>        </item>
        <item>
            <title>New health ministers  named</title>
            <link>http://www.medworm.com/index.php?rid=2479984&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fmumd2p</link>
            <description>Two new health ministers have been named at the Department of Health as the Government reshuffle continues.
Mike O'Brien, previously a minister at the Department for Energy and Climate Change, and Gillian Merron, a minister in the Foreign and Commonwealth Office, have been appointed to replace outgoing ministers Ben Bradshaw and Dawn Primarolo. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2479984</comments>
            <pubDate>Mon, 15 Jun 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2479984</guid>        </item>
        <item>
            <title>NIHR Invention for Innovation  Programme 3rd Call for proposals opens on  27 May 2009</title>
            <link>http://www.medworm.com/index.php?rid=2408132&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nihr-ccf.org.uk%2Fsite%2Fprogrammes%2Fi4i</link>
            <description>NIHR Invention for Innovation (i4i) Programme 3rd Call for proposals opens on 27 May 2009
 i4i Future Product Development - Funding Stream 1 (FPD1)
The National Institute for Health Research (NIHR) would like to invite FPD1 project proposals of up to £100K for a maximum duration of 12 months under its i4i Programme to investigate whether a piece of prior basic research or an innovative use of an existing technology can be used to meet an existing or emerging healthcare need. There should be the potential for a device, based on the technology or technologies, to be developed through further applied R&amp;D. The study must also identify the barriers that would need to be overcome before implementation. 
All applications must show innovation and must have relevance, impact and potential to c...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2408132</comments>
            <pubDate>Wed, 13 May 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2408132</guid>        </item>
        <item>
            <title>Department of Health new Commercial Operating Model</title>
            <link>http://www.medworm.com/index.php?rid=2400592&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fqjhdz3</link>
            <description>The Department of Health has published a new Commercial Operating Model entitled 'Necessity - not nicety: A new Commercial Operating Model for DH and NHS' 
The Commercial Operating Model will improve support and increase commercial capability throughout the NHS by:  

 creating    new regional Commercial Support    Units (CSUs), offering a range of dedicated commercial support to NHS    health care providers and service commissioners to help them improve their    skills, gain better value from procurement and respond more effectively to    the commercial challenges of operating in todays NHS. PCTs will not    advance past level 1 for World Class Commissioning competencies relating    to stimulate the market and secure better procurement skills, unless    they develop the functio...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2400592</comments>
            <pubDate>Fri, 08 May 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2400592</guid>        </item>
        <item>
            <title>Demand Pull Workshops - an opportunity for Industry and Research Community</title>
            <link>http://www.medworm.com/index.php?rid=2393087&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fca5dcr</link>
            <description>As part of the work of the Ministerial Medical Technology Strategy Group NHS Technology Adoption Centre has been looking at new processes for driving Demand Pull. Putting Clinicians to the fore in defining the technologies required to satisfy unmet clinical needs.
They have been working with the Cardiac Networks in the North of England and London to run two workshops which brought clinicians together from across the Heart Failure pathways. The Workshops debated the technologies which are currently seen as standard of care and those that are in the pipeline or in use in early adopter sites.
The teams then explored where gaps exist and where there are real opportunities to support the unmet clinical needs with new technology.
The next steps will be to hold two workshops

 18 June 2009 in...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2393087</comments>
            <pubDate>Tue, 05 May 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2393087</guid>        </item>
        <item>
            <title>Is the UK falling behind in clinical trials?</title>
            <link>http://www.medworm.com/index.php?rid=2355144&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.pharmafocus.com%2Fcda%2FfocusH%2F1%2C2109%2C21-0-0-APR_2009-focus_news_detail-0-492688%2C00.html</link>
            <description>New initiatives to bolster collaboration between the NHS, academia and industry have come amid claims that the UK is losing its standing in clinical trials. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2355144</comments>
            <pubDate>Tue, 21 Apr 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2355144</guid>        </item>
        <item>
            <title>Are you ready to run the gauntlet?</title>
            <link>http://www.medworm.com/index.php?rid=2343823&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.hatchedby.us%2Fgauntlet_next.html</link>
            <description>Are you looking for funding?
 Help with your business plan?
 Advice on presentation style?

UKTI and The Hatchery in New York are offering UK SMEs the opportunity to bid to US Venture Capitalists for funding. The event takes place in New York on 23 September 2009. If you think you have what it takes to succeed in New York, put your idea to the test at The Hatchery Gauntlet Event. You will have seven minutes to present your business models to select specialists from the NY Venture Capital Community.
UK Trade &amp; Investment (UKTI), the international business development agency for the British Government, is co-hosting this exciting event. UK ICT start up companies within the interactive advertising, e-security, digital media and mobile sectors will receive mentoring and training in the fol...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2343823</comments>
            <pubDate>Mon, 20 Apr 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2343823</guid>        </item>
        <item>
            <title>NIHR Invention for Innovation Programme - 1st Call for proposals - i4i Future Product Development - Funding Stream 3a (FPD3a)</title>
            <link>http://www.medworm.com/index.php?rid=2334393&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.nihr-ccf.org.uk%2Fsite%2Fprogrammes%2Fi4i%2F</link>
            <description>NIHR Invention for Innovation (i4i) Programme
1st Call for proposals - i4i Future Product Development - Funding Stream 3a (FPD3a)
The NIHR Invention for Innovation (i4i) programme would like to invite submissions of proposals to its Future Product Development 3a funding stream (FPD3a). Proposals must include collaboration between at least one industry and one research (academic or clinical) partner to determine the commercial viability of a proposed device or technology, with the development of a robust route to market and a strong, appropriate consortia being the main deliverables. Serving primarily as the first stage of a full collaborative applied research project, total project costs can be no more than £100K in total, of which 75% funding is available. 
All applications must show inn...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2334393</comments>
            <pubDate>Wed, 15 Apr 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2334393</guid>        </item>
        <item>
            <title>MHRA to provide information through social networking sites</title>
            <link>http://www.medworm.com/index.php?rid=2334392&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fdhgpyd</link>
            <description>The Medicines and Healthcare products Regulatory Agency (MHRA) has set out how it plans to improve its communication with patients and the public over the next two years. See http://www.healthcarerepublic.com/news/PHARMACIST/898281/MHRA-provide-information-social-networking-sites/ for further information. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2334392</comments>
            <pubDate>Wed, 15 Apr 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2334392</guid>        </item>
        <item>
            <title>East of  England Strategic Health Authority launches three new SBRI competitions</title>
            <link>http://www.medworm.com/index.php?rid=2334394&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.hee.org.uk</link>
            <description>The East of England Strategic Health Authority is launching three new SBRI competitions in April.&amp;nbsp; The topic areas for ideas and new technologies are:
Managing Long Term Conditions: 
 Increasingly, more people are living with long term conditions and quite apart from the personal issues this creates; it poses a significant challenge to the local health service.&amp;nbsp; We are looking for ideas and technologies that can be shown to make a difference in managing long term conditions.&amp;nbsp; Specific areas that address the remote monitoring of patients combined with decision support to enable better care from home and innovative solutions to data and systems management with relation to patient care.
Patient Safety and improving health outcomes:
 This competition is focused on the area of pa...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2334394</comments>
            <pubDate>Wed, 08 Apr 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2334394</guid>        </item>
        <item>
            <title>NEW REPORT: Products, devices, treatments and technologies for urinary continence in adults</title>
            <link>http://www.medworm.com/index.php?rid=2309954&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.ennovations.co.uk</link>
            <description>This report will assist new players in the field to gain an understanding of urinary tract dysfunction, and also help to identify potential gaps and opportunities for innovation. It will be particularly useful for:

 non-clinical partners engaged in research, sales, marketing or product development
 non-specialist clinicians who require an overview


 The report describes, in broad terms, the most common causes of bladder and urethral dysfunction in adults, focusing on symptoms, prevalence and the various treatment options available, including an indication of the evidence for their use. 
 It comprises the following sections:

  Understanding Urinary Incontinence
   Stress Urinary Incontinence
   Urgency Urinary Incontinence
  Voiding Difficulties

To purchase a copy of the report (£3...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309954</comments>
            <pubDate>Tue, 07 Apr 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309954</guid>        </item>
        <item>
            <title>New government office established to reinforce success of life sciences industry</title>
            <link>http://www.medworm.com/index.php?rid=2309953&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.healthtechktn.com</link>
            <description>A new Office for Life Sciences (OLS) has been created to address key issues affecting the pharmaceutical, medical biotech and devices sectors.The OLS is tasked, by the end of July 2009, with taking action to make a real difference to the operating environment for life sciences companies by working across Government to address a range of key issues, including those raised in The Review and Refresh of Bioscience 2015.Working with Departments who are responsible for these areas, this virtual Office will co-ordinate national policy, undertaking work to build a sustainable and integrated life sciences industry in the future. It will look at what steps can be taken to improve access to finance for SMEs and to stimulate investment in the life sciences industry.  It will also be considering how th...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309953</comments>
            <pubDate>Tue, 07 Apr 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309953</guid>        </item>
        <item>
            <title>RCUK Launch new Knowledge Transfer Portal</title>
            <link>http://www.medworm.com/index.php?rid=2309952&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.rcuk.ac.uk%2Finnovation%2Fktportal%2Fdefault.htm</link>
            <description>The Research Councils UK (RCUK) Knowledge Transfer Portal offers a single point of access for those in, e.g., academia, business, public, private and/or third sectors, who want to find out about Research Council knowledge transfer schemes and activities, and how to get involved. You will find links to Research Council funding opportunities, current events, networks, and training courses, just to name a few. See http://www.rcuk.ac.uk/innovation/ktportal/default.htm (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309952</comments>
            <pubDate>Tue, 07 Apr 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309952</guid>        </item>
        <item>
            <title>Healthcare Oscars award cream of sector</title>
            <link>http://www.medworm.com/index.php?rid=2288833&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.healthtechktn.com</link>
            <description>Healthcare excellence and innovation was top of the agenda this week as the countrys best healthcare companies were recognised at the Medilink UK Awards 2009  the Healthcare Technologies sectors equivalent to the Oscars.Sponsored by Xiros plc, the Medilink UK annual awards celebrate cutting edge technologies, outstanding business achievements and international success and collaboration; showcasing the cream of the countrys healthcare industry.
Held in London on Monday 16th March, the nominees for each of the five awards  Export Achievement, Innovation, Growth in Sector, Partnership with the NHS and Start Up  were made up of winners from the regional Medilink Awards selected by a panel of sector specialists from the 12 UK regions. The UK Trade &amp; Investment (UKT&amp;I) Export Achieve...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2288833</comments>
            <pubDate>Thu, 19 Mar 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2288833</guid>        </item>
        <item>
            <title>ERBI Medtech and Cambridge Wireless launches new report  'Is the future of medical devices wireless?'</title>
            <link>http://www.medworm.com/index.php?rid=2288834&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.erbi.co.uk%2Fpooled%2Farticles%2FBF_NEWSART%2Fview.asp%3FQ%3DBF_NEWSART_310774</link>
            <description>A dedicated frequency band for medical devices would boost confidence and stimulate uptake of wireless technology within a healthcare environment. This is one of the recommendations of a new report launched by ERBI Medtech. The report 'Is the future of medical devices wireless?' was produced following a facilitated workshop, which brought together experts from the fields of medical device development, wireless technology and healthcare. The aim was to discuss the issues that face technologists when developing devices for a range of healthcare environments including assisted living and hospitals and propose a roadmap for moving the industry forward. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2288834</comments>
            <pubDate>Mon, 16 Mar 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2288834</guid>        </item>
        <item>
            <title>Technology Strategy Board  Innovation Platform for the Detection and Identification of  Infectious Agents</title>
            <link>http://www.medworm.com/index.php?rid=2288835&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.innovateuk.org</link>
            <description>The Technology Strategy Board has created a new Innovation Platform for the Detection and Identification of Infectious Agents in which it will invest up to £50 million over the next 5 years. The initiative will also see investment from the NIHR, which on behalf of the Department of Health, will invest between £500,000 and £1 million a year over the same period. The programme will look at how new technology might be developed to help minimise the impact of the threat of infectious diseases. The Technology Strategy Board is working closely with the Department of Health and Department for Environment, Food and Rural Affairs (DEFRA) and other organisations in both the public and private sector to prioritise the disease areas, and determine the product capabilities and specifications likely ...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2288835</comments>
            <pubDate>Fri, 13 Mar 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2288835</guid>        </item>
        <item>
            <title>Web 2.0 woven into health information's future</title>
            <link>http://www.medworm.com/index.php?rid=2288837&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.bcs.org%2Fserver.php%3Fshow%3DConWebDoc.24638</link>
            <description>This article reports on a BCS Thought Leadership Debate, which considered that question. Read the article at http://www.bcs.org/server.php?show=ConWebDoc.24638 (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2288837</comments>
            <pubDate>Wed, 04 Mar 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2288837</guid>        </item>
        <item>
            <title>The cream of the UK healthcare technology sector is announced</title>
            <link>http://www.medworm.com/index.php?rid=2288836&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.medilinkuk.com</link>
            <description>The nominees for the Medilink UK Awards 2009  the healthcare technologies sectors equivalent to the Oscars  have been announced.
The Medilink UK Awards, sponsored by Xiros Plc, celebrate cutting edge technologies, outstanding business achievements and international success and collaboration and have been designed to showcase the cream of the healthcare industry. 
Held at Haberdashers Hall, London on Monday 16th March, the Medilink UK Awards 2009 is being run in association with UK Trade &amp; Investment (UKT&amp;I), Health Technologies KTN, BERR (Department for Business Enterprise and Regulatory Reform, the NHS National Innovation Centre (NIC) and NIHR (National Institute for Health Research).
The nominees for each of the five awards  Export Achievement, Innovation, Growth in Sec...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2288836</comments>
            <pubDate>Wed, 04 Mar 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2288836</guid>        </item>
        <item>
            <title>Innovation Research Initiative - Distributed Projects</title>
            <link>http://www.medworm.com/index.php?rid=2288838&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Ftinyurl.com%2Fbxsfwc</link>
            <description>The Economic and Social Research Council (ESRC), in funding partnership with the Department for Innovation, Universities and Skills (DIUS), the National Endowment for Science, Technology and the Arts (NESTA) and the Technology Strategy Board (TSB), is commissioning independent, multidisciplinary research focused on the role, drivers and impact of innovation.As the first phase of the Initiative, The Cambridge-Imperial Innovation Research Centre (UK~IRC) is receiving funding to host a strategic research and capacity building programme together with a knowledge exchange hub. As the second phase of the Initiative, the partners are now commissioning distributed projects. The Call is divided into two types of projects:Substantive research projects with a Full Economic Costing (FEC) between £250...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2288838</comments>
            <pubDate>Mon, 02 Mar 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2288838</guid>        </item>
        <item>
            <title>Innovative Manufacturing Research Centres (IMRCs) 2009 Call</title>
            <link>http://www.medworm.com/index.php?rid=2288839&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.imrcs-health.org</link>
            <description>EPSRC is inviting applications for centres in innovative manufacturing to fill gaps in the current IMRC portfolio. The centres will be supported under a new funding model and will not take the form of a 5-year block grant (as is the case for existing centres). See http://www.imrcs-health.org for more information. (Source: Health Technologies KTN News)</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2288839</comments>
            <pubDate>Fri, 27 Feb 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2288839</guid>        </item>
        <item>
            <title>Matera+ call march 2009</title>
            <link>http://www.medworm.com/index.php?rid=2288840&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.innovateuk.org%2Fdeliveringinnovation%2Finternationalprogramme%2Fmatera.ashx</link>
            <description>MATERA+ is an ERA-NET+ Action focusing on material science and engineering. ERA-NET+ Actions are an initiative of the European Commission [EC] aimed at providing additional EC financial support to those national and regional programmes that pool resources to organise a joint call for proposals. MATERA+ is a follow-on to the MATERA+ ERA-NET, which focuses on creating a durable cooperation platform for national and regional policy makers and managers with strategic activities in material sciences and engineering.
MATERA+ Call: March 2009
There is an allocated and indicative budget of 1.5M euro to support UK industry and associated S&amp;T organisations within MATERA +

 Important dates


 16th March 2009 Opening of the Call
 15th May 2009 Pre-Proposal deadline
 15th October 2009 Invitation t...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2288840</comments>
            <pubDate>Tue, 24 Feb 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2288840</guid>        </item>
        <item>
            <title>Proposal to establish a healthy ageing research industry club</title>
            <link>http://www.medworm.com/index.php?rid=2288841&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.sparc.ac.uk%2Fmedia%2Fdownloads%2FHealthyAgeingClubProposalV2.pdf</link>
            <description>The Biotechnology and Biological Sciences Research Council (BBSRC) is the principal public sector funder of non-medical research in the biosciences in the UK, supporting some £400M pa of research and training in universities, and in its five sponsored institutes. Ageing research into lifelong health and well being is a research priority for the BBSRC and in addition to supporting fundamental research in this area the Council is also keen to support high quality strategic research of relevance to industry. Therefore, BBSRC has held discussions with colleagues in the academic and industrial community to consider whether there is scope for a generic programme of industrially relevant, innovative research on healthy ageing. If set up such a programme would improve the ability of a wide range ...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2288841</comments>
            <pubDate>Mon, 23 Feb 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2288841</guid>        </item>
        <item>
            <title>Bioscience 2015 Review and Refresh Report</title>
            <link>http://www.medworm.com/index.php?rid=2288842&amp;cid=s_38369_21_f&amp;fid=38369&amp;url=http%3A%2F%2Fwww.bioindustry.org%2Fbigtreport%2F</link>
            <description>The Bioscience 2015 Review and Refresh report is now available. The recommendations of this independent, industry-led report are the work of a broad coalition of stakeholders, chaired by Sir David Cooksey, including industry, the finance community, patient groups, research councils, academia and input from various Government Departments, who have worked on this over the past year.The recommendations build on those in the original Bioscience 2015 report published in 2003, the most influential report on the UK bioscience sector produced at that time, and supported by the then Prime Minster, Tony Blair. The Review and Refresh report both tracks progress against the original recommendations and makes new ones in the light of the current operating environment for bioscience companies.The Biosci...</description>
            <author>Health Technologies KTN News</author>
            <type>organizations</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2288842</comments>
            <pubDate>Thu, 19 Feb 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2288842</guid>        </item>
    </channel>
</rss>

